The cycle6 min
Premenstrual symptoms in a handful of trials
People take saffron for the days before a period. In small trials, symptom scores moved more than with placebo. The authors are more confident than the evidence is wide.
People take saffron hoping the days before a period will be easier, in mood and in the body. The trials that looked at that hope are fewer than the mood trials, and in them a daily extract did move symptom scores more than placebo. The object of study is still a prepared extract on a schedule, not a pinch in food. What follows is a reading of those trials. It is not a dose, and it is not a plan for a period. Why the two amounts do not convert is on the pinch and the capsule.
A 2008 double-blind trial assigned women to 30 milligrams a day of saffron stigma, split as 15 milligrams in the morning and 15 milligrams in the evening, or to placebo, across two menstrual cycles. Symptom scores and a depression scale moved more with saffron. The authors wrote that saffron could be an alternative treatment for premenstrual syndrome. That sentence is theirs, and it stays in the paper. The record is PubMed 18271889.
A later trial enrolled 120 women with premenstrual dysphoric disorder and compared saffron at 15 milligrams twice a day, fluoxetine at 20 milligrams twice a day, and placebo, across the two luteal weeks of two cycles. On one daily symptom scale, saffron separated from placebo. On the Hamilton depression scale, the three groups did not clearly separate. Fluoxetine brought more adverse effects. The record is PubMed 33457343. A difference on one scale, and not on another, is a finding with its limit already visible. It is not a reason to replace a prescribed medicine.
A 2026 meta-analysis pooled seven randomized trials and 612 participants. For premenstrual symptoms, the authors reported a standardized mean difference of about minus 0.64. For period pain, the pooled difference was about minus 0.51, and the confidence interval ran from about minus 1.01 to minus 0.01. An interval that nearly includes no effect is a fragile result, and the pain finding should be read with that thinness in mind. The authors still called saffron beneficial for both. Their conclusion remains theirs. The record is PubMed 41151539.
If you might be pregnant, skip the extract. Ordinary seasoning is the food scale, and the pregnancy caution is written on the page for who should leave it alone. Gut complaints, and the amounts that stop being food, are on the harm page. A kitchen pinch in a family pot is still food, and it is not the capsule these trials used.
What the dried stigma looks like, before anyone crushes it, is on Saffron Threads. The gram, as a jar this suite could read, is on Saffron Price. The morning's labor, counted onto a plate, is on Saffron Cost. The older map, kept apart from a dose, is on Saffron History. If you are cooking, the bloom is on Saffron Cook, the rice is on Saffron Recipe, and the chicken, on another night, is on Saffron Chicken.
Also on this desk
- UnitsThe pinch and the capsule are not the same thing
- MoodWhat the mood trials measured
- HarmSide effects, and the range that is no longer food
- CautionWhen a supplement is the wrong next step
- SleepWhat the sleep trials measured
- EyesEyes, and a change smaller than one line
- The limitWhat the evidence does not support